These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24091478)

  • 1. Intravesical glycosaminoglycans in the management of chronic cystitis.
    Iacovelli V; Topazio L; Gaziev G; Bove P; Vespasiani G; Finazzi Agrò E
    Minerva Urol Nefrol; 2013 Dec; 65(4):249-62. PubMed ID: 24091478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans--a review.
    Madersbacher H; van Ophoven A; van Kerrebroeck PE
    Neurourol Urodyn; 2013 Jan; 32(1):9-18. PubMed ID: 22782909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical glycosaminoglycan replenishment with chondroitin sulphate in chronic forms of cystitis. A multi-national, multi-centre, prospective observational clinical trial.
    Nordling J; van Ophoven A
    Arzneimittelforschung; 2008; 58(7):328-35. PubMed ID: 18751498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GAG replenishment therapy for bladder pain syndrome/interstitial cystitis.
    Wyndaele JJJ; Riedl C; Taneja R; Lovász S; Ueda T; Cervigni M
    Neurourol Urodyn; 2019 Feb; 38(2):535-544. PubMed ID: 30592544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ls clinical practice aligned with the latest scientific evidence on GAG therapy?
    Janssen DAW
    Urologia; 2017 Sep; 84(Suppl 1):16-20. PubMed ID: 28862729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological changes of bladder mucosa in patients who underwent instillation with combined sodium hyaluronic acid-chondroitin sulphate (Ialuril®).
    Costantini E; Lazzeri M; Pistolesi D; Del Zingaro M; Frumenzio E; Boni A; Pietropaolo A; Fragalà E; Porena M
    Urol Int; 2013; 91(1):81-8. PubMed ID: 23485915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
    Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
    Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of glycosaminoglycans in the management of chronic pelvic pain: a systematic review.
    Iacovelli V; Bianchi D; Pletto S; Pacini P; Fede Spicchiale C; Finazzi Agrò E
    Minerva Urol Nefrol; 2020 Jun; 72(3):321-331. PubMed ID: 32182229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis.
    Nickel JC; Egerdie B; Downey J; Singh R; Skehan A; Carr L; Irvine-Bird K
    BJU Int; 2009 Jan; 103(1):56-60. PubMed ID: 18778342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravesical instillations for inflammatory and sensory chronic bladder diseases: Literature review and guide to clinical practice].
    Meyer F; Chen É; Berrogain N; Bosset PO; Campagne-Loiseau S; Cardot V; Charles T; Deffieux X; Donon L; Even L; Girard F; Hermieu JF; Hurel S; Klap J; Peyrat L; Thuillier C; Tibi B; Vidart A; Wagner L; Cornu JN
    Prog Urol; 2022 Apr; 32(5):388-399. PubMed ID: 35125316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intravesical glycosaminoglycan substitution therapy on bladder pain syndrome/interstitial cystitis, bladder capacity and potassium sensitivity.
    Daha LK; Riedl CR; Lazar D; Simak R; Pflüger H
    Scand J Urol Nephrol; 2008; 42(4):369-72. PubMed ID: 19230170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injections.
    Dellis A; Papatsoris AG
    Expert Opin Investig Drugs; 2014 Jun; 23(6):751-7. PubMed ID: 24749738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence.
    Lazzeri M; Hurle R; Casale P; Buffi N; Lughezzani G; Fiorini G; Peschechera R; Pasini L; Zandegiacomo S; Benetti A; Taverna G; Guazzoni G; Barbagli G
    Ther Adv Urol; 2016 Apr; 8(2):91-9. PubMed ID: 27034722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical chondroitin sulphate for interstitial cystitis/painful bladder syndrome.
    Downey A; Hennessy DB; Curry D; Cartwright C; Downey P; Pahuja A
    Ulster Med J; 2015 Oct; 84(3):161-3. PubMed ID: 26668417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of instillation treatment with hyaluronic acid in relieving symptoms in patients with BPS/IC and uncomplicated recurrent urinary tract infections - Long-term results of a multicenter study.
    Scarneciu I; Bungau S; Lupu AM; Scarneciu CC; Bratu OG; Martha O; Tit DM; Aleya L; Lupu S
    Eur J Pharm Sci; 2019 Nov; 139():105067. PubMed ID: 31499170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis?
    Iavazzo C; Athanasiou S; Pitsouni E; Falagas ME
    Eur Urol; 2007 Jun; 51(6):1534-40; discussion 1540-1. PubMed ID: 17383810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC).
    Chuang YC; Chermansky C; Kashyap M; Tyagi P
    Expert Opin Investig Drugs; 2016; 25(5):521-9. PubMed ID: 26940379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of sodium hyaluronate and sodium chondroitin sulphate in the management of bladder disease.
    Damiano R; Cicione A
    Ther Adv Urol; 2011 Oct; 3(5):223-32. PubMed ID: 22046200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome.
    Nickel JC; Hanno P; Kumar K; Thomas H
    Urology; 2012 Jun; 79(6):1220-4. PubMed ID: 22516357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Available evidence about efficacy of different restoring agents of glycosaminoglycans for intravesical use in interstitial cystitis].
    Arance I; Ramón de Fata F; Angulo JC; González-Enguita C; Errando C; Cozar JM; Esteban M
    Actas Urol Esp; 2013 Feb; 37(2):92-9. PubMed ID: 23260184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.